Marshall Wace North America L.P. Has $2.45 Million Stock Holdings in Davita Inc (NYSE:DVA)

Marshall Wace North America L.P. boosted its holdings in shares of Davita Inc (NYSE:DVA) by 3,449.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 45,143 shares of the company’s stock after acquiring an additional 43,871 shares during the period. Marshall Wace North America L.P.’s holdings in Davita were worth $2,452,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Oregon Public Employees Retirement Fund grew its stake in Davita by 0.5% during the first quarter. Oregon Public Employees Retirement Fund now owns 36,727 shares of the company’s stock worth $1,994,000 after buying an additional 185 shares during the period. Securian Asset Management Inc raised its holdings in Davita by 1.7% in the first quarter. Securian Asset Management Inc now owns 13,178 shares of the company’s stock valued at $715,000 after acquiring an additional 217 shares in the last quarter. CSat Investment Advisory L.P. raised its holdings in Davita by 61.8% in the fourth quarter. CSat Investment Advisory L.P. now owns 581 shares of the company’s stock valued at $30,000 after acquiring an additional 222 shares in the last quarter. Piedmont Investment Advisors Inc. raised its holdings in Davita by 3.3% in the first quarter. Piedmont Investment Advisors Inc. now owns 6,974 shares of the company’s stock valued at $379,000 after acquiring an additional 225 shares in the last quarter. Finally, Moody National Bank Trust Division raised its holdings in Davita by 0.3% in the first quarter. Moody National Bank Trust Division now owns 87,943 shares of the company’s stock valued at $4,775,000 after acquiring an additional 248 shares in the last quarter. Institutional investors own 87.65% of the company’s stock.

A number of analysts recently weighed in on DVA shares. Zacks Investment Research raised shares of Garrett Motion from a “sell” rating to a “hold” rating in a report on Friday, May 10th. William Blair reaffirmed an “outperform” rating on shares of American Software in a report on Thursday, June 20th. Finally, Deutsche Bank cut shares of Mitsubishi Motors from a “buy” rating to a “hold” rating in a report on Thursday, May 9th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and four have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of $67.78.

Shares of DVA traded up $0.49 during midday trading on Friday, hitting $56.90. The stock had a trading volume of 2,171,017 shares, compared to its average volume of 2,195,922. Davita Inc has a fifty-two week low of $43.40 and a fifty-two week high of $79.11. The stock’s 50-day moving average price is $51.06. The company has a market capitalization of $9.47 billion, a price-to-earnings ratio of 15.94, a P/E/G ratio of 0.61 and a beta of 1.59. The company has a current ratio of 1.12, a quick ratio of 1.11 and a debt-to-equity ratio of 2.06.

Davita (NYSE:DVA) last posted its quarterly earnings results on Tuesday, May 7th. The company reported $0.91 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.95 by ($0.04). The company had revenue of $2.74 billion during the quarter, compared to analysts’ expectations of $2.82 billion. Davita had a return on equity of 13.96% and a net margin of 1.15%. Davita’s revenue for the quarter was down 3.7% compared to the same quarter last year. During the same period last year, the company earned $1.05 earnings per share. On average, equities analysts anticipate that Davita Inc will post 4.23 earnings per share for the current year.

Davita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

Recommended Story: Hold Rating

Institutional Ownership by Quarter for Davita (NYSE:DVA)

Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.